Skip to main content
. 2018 Jun 21;23(25):1700796. doi: 10.2807/1560-7917.ES.2018.23.25.1700796

Figure 2.

Lexis diagram showing the ageing of the yearly cohorts (1996–2023) and the period of reported cases for measles, collection times for the seroprevalence surveys (2009 and 2013), vaccination coverage information, age of vaccination and years of interest (2018 and 2020), study on the resurgence risk for measles, mumps and rubella in France in 2018 and 2020

MMR 1: first dose of measles-mumps-rubella vaccine; MMR 2: second dose of measles-mumps-rubella vaccine.

Figure 2